Harley Street Clinic
Harley Street Clinic
United Kingdom, London
Multiple sclerosis treatment cost in United Kingdom typically includes maintenance procedures like plasmapheresis, which ranges from $2,500 to $4,000, and specialized medication treatment for multiple sclerosis running from $25,000 to $40,000. Expenses depend heavily on disease severity, disability level, and the chosen clinical setting. While NHS covers many residents, private patients often seek care in London.
Typical Multiple Sclerosis Treatment Costs in United Kingdom
Bookimed Expert Insight: Patients seeking high-tier private care benefit from London's concentrated medical infrastructure. Wellington Hospital, the largest private clinic in the UK, offers 52 specialized departments for complex cases. For those requiring innovative approaches, Princess Grace Hospital is recognized as one of London's most innovative clinics. International patients often choose London Bridge Hospital for its 24/7 medical assistance and verified 4-star patient rating.
| United Kingdom | Turkey | Austria | |
| Plasmapheresis | from $2,500 | from $1,200 | from $2,000 |
| Multiple sclerosis rehabilitation | from $7,500 | from $3,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $25,000 | from $100 | from $2,000 |
| Therapeutic Apheresis | - | from $1,350 | - |
| Plasma Exchange | - | from $3,900 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.
Disease-Modifying Therapies (DMTs) are specialized medications that target the underlying immune process in Multiple Sclerosis. These drugs reduce relapse frequency and slow disability progression. A wide range of approximately 20 approved DMTs is currently available on the NHS for eligible patients.
Bookimed Expert Insight: While private centers like Wellington Hospital provide expert neurorehabilitation, medication costs in the UK private sector are significant. For example, Ocrevus treatment can cost between $35,000 and $55,000 per cycle. Patients should verify if their private neurologist can facilitate an NHS pathway transition to manage these long-term drug costs effectively.
Patient Consensus: Patients note that documenting every relapse and bringing complete MRI records is vital for proving eligibility. They also suggest checking if a local hospital can continue a specific drug before moving areas.
Eligibility for disease-modifying therapy (DMT) depends on a confirmed diagnosis of relapsing multiple sclerosis. Specialists evaluate active inflammation via MRI scans and recent clinical relapses. Neurologists use the Expanded Disability Status Scale (EDSS) to measure functional impairment before recommending specific treatments.
Bookimed Expert Insight: London clinics like Wellington Hospital emphasize integrated neurorehabilitation alongside DMTs to maximize mobility. While some facilities use a step-up model, CARF-accredited centers often provide early access to high-efficacy medications like Ocrevus for patients with rapid disease progression. This proactive approach helps minimize long-term nerve damage more effectively than waiting for milder treatments to fail.
Patient Consensus: Patients note that access to high-efficacy drugs often depends on having clear MRI evidence of breakthrough activity. It is helpful to bring a detailed log of symptoms and previous scans to every consultation to avoid funding delays.
Progressive multiple sclerosis treatment in the United Kingdom focuses on slowing disability and managing symptoms. Ocrelizumab remains the primary drug for primary progressive MS. For active secondary progressive MS, specialists prescribe Siponimod. Therapeutic apheresis and specialized neurorehabilitation are also available at advanced London centers.
Bookimed Expert Insight: Rehabilitation often provides more immediate quality-of-life improvements than drugs alone in progressive cases. Wellington Hospital holds CARF accreditation for neurorehabilitation, which is rare. This credential signals a higher standard for restoring function compared to general physical therapy clinics.
Patient Consensus: Patients note that goals must remain realistic as treatments aim for stability rather than recovery. Many emphasize that managing bladder issues and fatigue is just as vital as finding the right medication.
Managing day-to-day multiple sclerosis symptoms involves combining specialized medications, targeted neurorehabilitation, and lifestyle adjustments. UK clinics utilize advanced therapies like Ocrevus (ocrelizumab) and plasmapheresis to control progression. Individualized plans prioritize energy conservation, mobility assistance, and cognitive support to enhance daily functionality.
Bookimed Expert Insight: The Wellington Hospital in London holds CARF accreditation specifically for neurorehabilitation. This specialized certification indicates a higher standard for managing complex MS symptoms compared to general facilities. Patients benefit from a network that treats over 800,000 people annually, ensuring access to high-volume expertise.
Patient Consensus: Patients emphasize performing demanding tasks shortly after waking to maximize limited energy. They also recommend keeping written notes and turning off phone notifications to reduce cognitive brain fog.
Multiple sclerosis treatment options vary across the United Kingdom due to devolved healthcare policies and regional funding decisions. National agencies like NICE and the SMC approve disease-modifying therapies at different rates. Access often depends on regional integrated care boards or local health board priorities.
Bookimed Expert Insight: Patient volume is a major indicator of specialized infrastructure in London. Wellington Hospital serves 800,000 patients annually and holds CARF accreditation for neurorehabilitation. This specialized credential suggests that larger regional hubs may offer more structured long-term recovery support than general local clinics.
Patient Consensus: Patients note that the responsiveness of local MS nurses is often more important than the hospital size. Many emphasize researching specific regional centers as some teams are more proactive with newer treatments than others.
For urgent questions about your multiple sclerosis care plan in the United Kingdom, contact your named MS nurse first. They serve as the primary clinical link for symptom management and medication queries. If unavailable, contact your neurology clinic or General Practitioner to escalate the request.
Bookimed Expert Insight: UK clinics often provide specific specialized support structures. Princess Grace Hospital offers 24/7 assistance for every patient. Wellington Hospital serves 800,000 patients annually and provides dedicated neurorehabilitation. Choosing centers with high patient volumes and round-the-clock support ensures faster responses for complex multiple sclerosis needs.
Patient Consensus: Patients note it is important to request a written contact pathway during your first appointment. They emphasize that the MS Society helpline is a reliable backup for navigating the healthcare system.